» Articles » PMID: 1544886

Activation of P21ras by Transforming Growth Factor Beta in Epithelial Cells

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1992 Mar 15
PMID 1544886
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

The transforming growth factor beta (TGF beta) family members are ubiquitously expressed and control a variety of cellular processes by interacting with at least two types of high affinity cell surface receptors. However, the primary signal transduction mechanism of the receptors is unknown. The ras-encoded 21-kDa GTP binding proteins have recently been shown to mediate the effects of other polypeptide growth factors. Here we show that both TGF beta 1 and TGF beta 2 (5 ng/ml) result in a rapid (within 6 or 12 min, respectively) stimulation of GTP bound to p21ras in TGF beta-sensitive intestinal epithelial cells. Further, the CCL64 epithelial cell line, extremely sensitive to growth inhibition by TGF beta, displayed a concentration-dependent increase in GTP bound to p21ras by TGF beta 1 and a rapid activation of p21ras by TGF beta 2. The results provide the first direct evidence for rapid activation of a receptor coupling component for TGF beta in epithelial cells.

Citing Articles

Dual Modulation of Canonical and Non-canonical TGF-β/ROS/Erk1/2 Pathways: Synergistic Activation of Nrf-2 and Antioxidant Enzymes (SOD1, GPx, HO-1) by Quercetin Loaded in Solid Lipid Nanoparticles and Curcumin in Atherosclerosis Therapy.

Shamsi M, Mohammadzadeh G, Hatami M, Roshanazadeh M, Noor-Behbahani M, Rashidi M Iran J Pharm Res. 2025; 23(1):e151428.

PMID: 40066126 PMC: 11892753. DOI: 10.5812/ijpr-151428.


TGF-β Modulated Pathways in Colorectal Cancer: New Potential Therapeutic Opportunities.

Fasano M, Pirozzi M, Miceli C, Cocule M, Caraglia M, Boccellino M Int J Mol Sci. 2024; 25(13).

PMID: 39000507 PMC: 11242595. DOI: 10.3390/ijms25137400.


Cell type-specific transforming growth factor-β (TGF-β) signaling in the regulation of salivary gland fibrosis and regeneration.

Munoz Forti K, Weisman G, Jasmer K J Oral Biol Craniofac Res. 2024; 14(3):257-272.

PMID: 38559587 PMC: 10979288. DOI: 10.1016/j.jobcr.2024.03.005.


Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies.

Bahar M, Kim H, Kim D Signal Transduct Target Ther. 2023; 8(1):455.

PMID: 38105263 PMC: 10725898. DOI: 10.1038/s41392-023-01705-z.


TGF-β in correlation with tumor progression, immunosuppression and targeted therapy in colorectal cancer.

Singh S, Gouri V, Samant M Med Oncol. 2023; 40(11):335.

PMID: 37855975 DOI: 10.1007/s12032-023-02204-5.